三级aa视频在线观看-三级国产-三级国产精品一区二区-三级国产三级在线-三级国产在线

您現(xiàn)在的位置: > Language Tips > Audio & Video > Special Speed News  
 





  Once-daily pill could simplify HIV treatment
[ 2006-02-06 15:57 ]


I’m Steve Ember with the VOA Special English Health Report.


Myers Squibb and Gilead Sciences have combined many H.I.V. drugs into a single pill
Sometimes the best medicine is more than one kind of medicine. Malaria, tuberculosis and H.I.V./AIDS, for example, are all treated with combinations of drugs.

But that can mean a lot of pills to take. It would be simpler if drug companies combined all the medicines into a single pill, taken just once a day.

Now, two companies say they have done that for people just starting treatment for H.I.V., the virus that causes AIDS. The companies are Bristol-Myers Squibb and Gilead Sciences.

They have developed a single pill that combines three drugs currently on the market. Bristol-Myers Squibb sells one of them under the name Sustiva. Gilead combined the others, Emtriva and Viread, into a single pill in two thousand four.

Combining drugs involves more than technical issues. It also involves issues of competition if the drugs are made by different companies. The new once-daily pill is the result of what is described as the first joint venture agreement of its kind in the treatment of H.I.V.

In January the New England Journal of Medicine published a study of the new pill. Researchers compared its effectiveness to that of the widely used combination of Sustiva and Combivir. Combivir contains two drugs, AZT and 3TC. The researchers say that after one year of treatment, the new pill suppressed H.I.V. levels in more patients and with fewer side effects.

Gilead paid for the study. Professor Joel Gallant at the Johns Hopkins School of Medicine in Baltimore, Maryland, led the research. He is a paid adviser to Gilead and Bristol-Meyers Squibb as well as the maker of Combivir, GlaxoSmithKline.

GlaxoSmithKline reacted to the findings by saying that a single study is of limited value. It says the effectiveness of Combivir has been shown in each of more than fifty studies.

The price of the new once-daily pill has not been announced. But Gilead and Bristol-Myers Squibb say they will provide it at reduced cost to developing countries.

They plan in the next few months to ask the United States Food and Drug Administration to approve the new pill.

There are limits to who could take it because of the different drugs it contains. For example, pregnant women are told not to take Sustiva because of the risk of birth disorders.

Experts say more than forty million people around the world are living with H.I.V.

This VOA Special English Health Report was written by Cynthia Kirk. Read and listen to our reports at voaspecialenglish.com. I’m Steve Ember.

Vocabulary

 

 

 
 
 




主站蜘蛛池模板: 婷婷在线视频 | 亚洲无成人网77777 | 久久有这有精品在线观看 | 精品久久香蕉国产线看观看亚洲 | 欧美一区二区三区播放 | 国产一级毛片一区二区三区 | 欧美一区二区在线观看视频 | 天堂一区二区三区精品 | 一级毛片特级毛片国产 | 欧美人成一本免费观看视频 | 国产玖玖玖精品视频 | 国产精品视频久久久久 | 日本xxwwwxxxx18| 欧美一级片黄色 | 亚洲国产精品a一区 | 国产精品白丝喷水在线观看 | 国产不卡一卡2卡三卡4卡5卡在线 | 日韩一区精品视频在线看 | 欧美一区二区三区性 | 亚洲成人一区 | 午夜国产高清精品一区免费 | 欧美三级在线免费观看 | 久热精品免费视频 | 尤物免费视频 | 黄色片视频在线观看 | 在线成人 | 国产特黄特色的大片观看免费视频 | 日韩第六页 | 日日麻批免费视频 | www.国产精品.com | 午夜激情在线观看 | 闫盼盼福利 | 亚洲欧美日韩国产 | 亚洲色图视频在线 | 成年人黄色网址 | 亚洲欧洲日韩另类自拍 | 亚洲午夜国产片在线观看 | 国产一级精品视频 | 特黄免费 | 一级做a免费视频观看网站 一级做a爰毛片 | 日本中文字幕不卡在线一区二区 |